Akari Therapeutics Plc (AKTX)
3.49
-0.21
(-5.68%)
USD |
NASDAQ |
May 15, 16:00
3.55
+0.06
(+1.72%)
After-Hours: 20:00
Akari Therapeutics EPS Diluted (Quarterly) : 0.00 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -0.5577 |
| Cellectis SA | -0.1774 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.28 |
| Autolus Therapeutics Plc | -0.2686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.290M |
| Total Expenses (Quarterly) | 5.290M |
| Enterprise Value | -0.5143M |
| Earnings Yield | -296.9% |